Tau protein is crucial in Alzheimer’s disease and dementia as it plays a central role in neurodegeneration. In Alzheimer’s, tau proteins malfunction, forming twisted tangles inside brain cells called neurofibrillary tangles. These tangles disrupt the cell's transport system, leading to the death of neurons and contributing to cognitive decline and memory loss characteristic of the disease. Research indicates that tau pathology correlates closely with cognitive impairment in Alzheimer’s patients, making it a significant target for therapeutic interventions. Understanding how tau proteins aggregate and spread throughout the brain is crucial for developing treatments that can slow or halt the progression of Alzheimer’s disease and other forms of dementia associated with tau pathology. Therefore, ongoing research focuses on elucidating tau's role in neurodegeneration to devise effective strategies for combating these devastating conditions.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States